Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease: the LAST-COP Study

NCT07588295 is registered in ClinicalTrials.gov with Maria Cecilia Hospital as lead sponsor.

NCT NCT07588295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease: the LAST-COP Study
Lead sponsor
Maria Cecilia Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2024
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, critical limb ischemia, intermittent claudication, stable coronary artery disease